Jove
Visualize
Contact Us

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DIO3 associates with sorting nexins and endosomal trafficking networks in ovarian cancer.

Cellular oncology (Dordrecht, Netherlands)·2026
Same author

Thrombin is increased in diabetic retinal pathology in the STZ mice model, and its attenuation by a specific inhibitor, PARIN5, is associated with preserved function.

Scientific reports·2026
Same author

Biphasic modulation of large-fiber excitability accompanied by dynamic nerve-intrinsic immune activation following CFA-induced peripheral inflammation in mice.

Scientific reports·2026
Same author

Neurofilament Light Chain Measurements by Centaur and Simoa Systems in Human and Murine Samples.

The Israel Medical Association journal : IMAJ·2026
Same author

Measuring Neural Factor X Pathway Activity in Rodent Glioma Cell Culture and Brain Slices.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects.

International journal of molecular sciences·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Hyperactivity induced by antiphospholipid syndrome serum.

Assaf Menachem1, Joab Chapman, Aviva Katzav

  • 1Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Annals of the New York Academy of Sciences
|September 18, 2009
PubMed
Summary

Antiphospholipid syndrome (APS) serum injected into mice brains caused behavioral changes. Further research is needed to understand if specific antibodies or other serum factors contribute to APS central nervous system effects.

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jun 20, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder.
  • APS is characterized by thrombosis, pregnancy complications, and neuropsychiatric symptoms.
  • Previous studies show intracerebroventricular (i.c.v.) injection of antiphospholipid IgG causes hyperactivity in mice.

Purpose of the Study:

  • To investigate the effects of whole-serum from APS patients administered i.c.v. on mouse behavior.
  • To compare the behavioral effects of APS serum versus healthy control serum and saline.

Main Methods:

  • Female Balb/C mice received i.c.v. injections of serum from APS patients, healthy controls, or saline.
  • Behavior was assessed using the staircase apparatus, measuring stair-climbing (locomotor activity) and rearing (anxiety).

Main Results:

  • Mice injected with APS serum showed a trend towards increased stair-climbing compared to controls.
  • A similar trend was observed in mice receiving normal human serum, suggesting non-specific effects or other factors.

Conclusions:

  • The study suggests that while antiphospholipid IgG may play a role, other serum components might also influence central nervous system (CNS) manifestations in APS.
  • Further investigation is required to differentiate the specific contributions of various serum factors to APS-related neurological symptoms.